Emma Walmsley, CEO of GlaxoSmithKline (GSK) has been nominated to join to the Microsoft board of directors.
Ms Walmsley was appointed CEO of GSK in April 2017 and has been a member of GSK’s corporate executive team since 2011.
“Emma is an accomplished business leader who led major advances in research and development at GSK and will bring her significant insights and global experience to Microsoft,” said John W. Thompson, Microsoft independent board chair.
“We believe she will be a valuable addition to the board.”
Ms Walmsley will be presented for election at the company’s annual shareholders meeting, which will be held December 4 2019.